This Biotech’s Stock Soaring After FDA Official Exits
Biotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
A solid budget helps young professionals manage irregular income and set aside funds for future goals.
19,780 articlesBiotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
When a titan like Alphabet slides, investors often panic. This time, the dip could unlock value. Here are three megac...
Tensions over Iran have flipped XRP into a geopolitics-driven asset. As the Iran conflict escalates, traders watch pr...
Apple is reportedly exploring a memory supplier in China to ease a chip shortage. Industry skeptics say the pivot won...
A group of lesser-known dividend ETFs is delivering stronger income and price gains as investors seek stability in a ...
NVIDIA stock steadies after a summer pullback as analysts largely stay bullish. Here’s a fresh look at the nvidia sto...
As regulators eye crypto privacy tools, the DOJ's push for an October retrial in the Tornado Cash case tests how far ...
Palantir has won a landmark Army data overhaul deal worth $10 billion, signaling a decade-long shift in defense IT an...
Ferrari's latest results underscore its asset-like status, delivering strong cash flow while preparing for an electri...
Memory prices and AI data demands have put Micron and Sandisk in the spotlight. This piece breaks down what’s driving...
Amazon returns to the bond market to fund AI infrastructure growth as hyperscalers shift from cash to credit. Analyst...
Anthropic faces a high-stakes regulatory battle in Washington that could redefine how AI startups grow and attract mo...